| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |